CVRS News and Press, Corindus Vascular Robotics Inc. (DE) From 04/29/19

Corindus Vascular Robotics, Inc. [NYSE American: CVRS], a leading developer of precision vascular robotics, today announced that it will release first quarter 2019 financial and business results on Tuesday, May 7, 2019 after the close of the U.S. financial markets. Mark Toland, President...

Japan represents one of the largest markets for PCI globally, with over 1,200 hospitals performing nearly 250,000 PCI procedures annually Corindus Vascular Robotics, Inc. (“Corindus” or the “Company”) (NYSE American: CVRS), a leading developer of pre...

Shares sold in private placement are subject to contractual six-month lock-up Corindus Vascular Robotics , Inc. (“Corindus” or the “Company”) (NYSE American: CVRS), a leading developer of precision vascular robotics, announced today that it filed a re...

Gainers : SPI Energy (NASDAQ: SPI ) +69% . Sorrento Therapeutics (NASDAQ: SRNE ) +34% . Phunware (NASDAQ: PHUN ) +33% . Neurotrope (NASDAQ: NTRP ) +17% . Electrameccanica Vehicles (NASDAQ: SOLO ) +14% . General Finance (NASDAQ: GFN ) +14% . Axsome Therapeutics (NASDAQ: AXSM ) +13% ....

Corindus Vascular Robotics ( CVRS +0.7% ) reports Q4 revenue growth of 11.5% Y/Y to $4.67M. More news on: Corindus Vascular Robotics, Inc. Read more ...

Corindus Vascular Robotics, Inc. (CVRS) Q4 2018 Earnings Conference Call March 12, 2019 4:30 P.M. ET Company Participants Mark Toland - Chief Executive Officer David Long - Chief Financial Officer Conference Call Participants Drew Ranieri - Stifel Jeffrey Cohen - Ladenburg ...

Corindus Vascular Robotics (NYSEMKT: CVRS ): Q4 GAAP EPS of -$0.04. More news on: Corindus Vascular Robotics, Inc., Earnings news and commentary, Consumer stocks news, Read more ...

Submitted Neurovascular Indication Marking Important Step toward Addressing Stroke Market; Raised $19.8 Million to Fund Ongoing Innovation Corindus Vascular Robotics , Inc. (NYSE American: CVRS), a leading developer of precision vascular robotics, today reported financial results for...

Corindus Vascular Robotics, Inc. (“Corindus” or the “Company”) [NYSE American: CVRS], a leading developer of precision vascular robotics, today announced the execution of an additional closing of the private placement previously announced on February 26, 2019. In ...

Corindus Vascular Robotics, Inc. (NYSE American: CVRS), a leading developer of precision vascular robotics, today announced that it will release fourth quarter and full year 2018 financial and business results on Tuesday, March 12, 2019 after the close of the U.S. financial markets. Mark...